Evidence map›Paper›PMID 41413171›Full record

ArticleScientific reports2025

Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.

Yee Peng Phoon, Alexandra A Wolfarth, Pauline Funchain, Jennifer S Ko, Donghoon Choi, Eliska Dedkova, Daniela Duarte Bateman, Jessica Corvin, Jan J Melenhorst, Brian R Gastman

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yee Peng PhoonCenter for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Alexandra A WolfarthNeoImmuneTech, Inc., Rockville, MD, 20850, USA.
Pauline FunchainStanford Cancer Institute, Stanford, CA, USA.
Jennifer S KoAnatomic Pathology, Cleveland Clinic, Cleveland, OH, 44195, USA.
Donghoon ChoiNeoImmuneTech, Inc., Rockville, MD, 20850, USA.
Eliska DedkovaCenter for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Daniela Duarte BatemanCenter for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Jessica CorvinCenter for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Jan J MelenhorstCenter for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. melenhj@ccf.org.
Brian R GastmanCenter for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. brian.gastman@iovance.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41413171
PMCPMC12714753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.